PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, 28644, Republic of Korea.\', \'Zoonotic Infectious Diseases Research Center, Chungbuk National University, Cheongju, 28644, Republic of Korea.\', \'GREENCROSS WellBeing Co., Ltd., Seoul, 07335, Republic of Korea.\', \'College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, 28644, Republic of Korea. choiki55@chungbuk.ac.kr.\', \'Zoonotic Infectious Diseases Research Center, Chungbuk National University, Cheongju, 28644, Republic of Korea. choiki55@chungbuk.ac.kr.\', \'GREENCROSS WellBeing Co., Ltd., Seoul, 07335, Republic of Korea. hjhan@gccorp.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s12275-021-1367-2
?:hasPublicationType
?:journal
  • Journal of microbiology (Seoul, Korea)
is ?:pmid of
?:pmid
?:pmid
  • 34613605
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Antiviral effects of human placenta hydrolysate (LaennecĀ®) against SARS-CoV-2 in vitro and in the ferret model.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all